Ameritas Investment Partners’s Immune Design Corp. IMDZ Stock Holding History

Ameritas Investment Partners’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,948	Closed	-$17K	–	3205
2019 Q1	$17K	Hold	2,948	–	–	﹤0.01%	2481
2018 Q4	$4K	Hold	2,948	–	–	﹤0.01%	2903
2018 Q3	$10K	Hold	2,948	–	–	﹤0.01%	2852
2018 Q2	$13K	Buy	2,948 +2,074	+237%	+$8.26K	﹤0.01%	2770
2018 Q1	$3K	Hold	874	–	–	﹤0.01%	2918
2017 Q4	$3K	Hold	874	–	–	﹤0.01%	2927
2017 Q3	$9K	Hold	874	–	–	﹤0.01%	2835
2017 Q2	$9K	Hold	874	–	–	﹤0.01%	2863
2017 Q1	$6K	Buy	+874	New	+$5.05K	﹤0.01%	2830

Ameritas Investment Partners's IMDZ Position: Q2 2019 in Review

Ameritas Investment Partners sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 2,948 shares — an estimated $17K sold.

Ameritas Investment Partners first reported a position in IMDZ in Q1 2017 and held it in 9 quarters. The position peaked at $17K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Ameritas Investment Partners reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Ameritas Investment Partners sold 2,948 Immune Design Corp. shares in Q2 2019, an estimated $17K.
Ameritas Investment Partners first reported a position in Immune Design Corp. in Q1 2017 and held it in 9 quarters.
Ameritas Investment Partners's Immune Design Corp. position peaked at $17K in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.